PMC9082281_01
T2W-TSE axial sections showing cystic dilatation (black arrow) at the primary confluence with internal, mural-based, frond-like hypointense contents (white arrow), extending to the common hepatic duct/CBD. Upstream dilated biliary radicles (green arrow) are observed with a mildly dilated CBD distally (red arrow).
SAJR-26-2387-g001.jpg
PMC9082281_01_SAJR-26-2387-g001.jpg
F0001
T2-weighted sequences and showed diffusion restriction. Triple phase contrast enhanced sequences showed late arterial enhancement in the mural soft tissue, with reduced enhancement on the porto-venous and delayed phases (Figure 1, Figure 2, Figure 3 and Figure 4).
Axial T2W-TSE (a) and T1-FFE (b) sections demonstrating an iso to hypointense mural-based growth (white arrow) projecting into the lumen of the common hepatic duct or CBD. High signal is observed within the lesion on the axial b-1000 DWI image (c) with low signal on the corresponding ADC map (d).
SAJR-26-2387-g002.jpg
PMC9082281_01_SAJR-26-2387-g002.jpg
F0002
T2-weighted sequences and showed diffusion restriction. Triple phase contrast enhanced sequences showed late arterial enhancement in the mural soft tissue, with reduced enhancement on the porto-venous and delayed phases (Figure 1, Figure 2, Figure 3 and Figure 4).
Dynamic post-contrast axial sequences revealing iso-intensity of the tumour (white arrow) on noncontrast (a), hyperenhancement on the late arterial phase (b), reduced hyperintensity on the porto-venous (c) and delayed (d) phases.
SAJR-26-2387-g003.jpg
PMC9082281_01_SAJR-26-2387-g003.jpg
F0003
T2-weighted sequences and showed diffusion restriction. Triple phase contrast enhanced sequences showed late arterial enhancement in the mural soft tissue, with reduced enhancement on the porto-venous and delayed phases (Figure 1, Figure 2, Figure 3 and Figure 4).
(a) Balanced Turbo Field Echo (BTFE) coronal section showing the dilated downstream common hepatic duct and CBD (black arrow), separate from the lesion at the primary confluence. The site and extent of the intraductal tumour is best seen on the volumetric MIP of the magnetic resonance pancreatico-cholangiography (b), indicating extension of the tumour into the common hepatic duct (white arrow) with upstream and downstream ductal dilatation.
SAJR-26-2387-g004.jpg
PMC9082281_01_SAJR-26-2387-g004.jpg
F0004
T2-weighted sequences and showed diffusion restriction. Triple phase contrast enhanced sequences showed late arterial enhancement in the mural soft tissue, with reduced enhancement on the porto-venous and delayed phases (Figure 1, Figure 2, Figure 3 and Figure 4).
(a) The patient underwent open hilar resection with standard lymphadenectomy and right and left Roux-en-Y-cholangiojejunostomy. Papillary growth was seen at the primary confluence, extending into the right hepatic duct. (b) Low-power photomicrograph (Hematoxylin & eosin [H & E] stain; magnification 10x) of the resected specimen showing papillary projections (black arrow) with a central fibrovascular core (green arrow). (c) High-power photomicrograph (H & E stain; magnification- 20x) showing irregular papillae with features of high-grade dysplasia and hyperchromatic nuclei (black arrow); goblet cells are also seen (white arrow). (d) Positive immunohistochemistry staining (brown) for MUC2 and MUC5 using recombinant antibodies.
SAJR-26-2387-g005.jpg
PMC9082281_01_SAJR-26-2387-g005.jpg
F0005
Histopathological analysis and Immunohistochemistry staining of the resected specimen confirmed the lesion to be an IPN-B (intestinal subtype, histological type 2 with high-grade dysplasia) restricted to the primary confluence and right hepatic duct, with tumour-free CBD, left hepatic duct and hepatic margins (Figure 5).